Optinose to Present at Leerink Partners 7th Annual Global Healthcare Conference
Feb 09, 2018 13:00 pm UTC| Business
YARDLEY, Pa., Feb. 09, 2018 -- Optinose (NASDAQ:OPTN), a pharmaceutical company focused on patients treated by ear, nose and throat (ENT) and allergy specialists, today announced that Chief Executive Officer Peter...
Feb 09, 2018 13:00 pm UTC| Business
NEW YORK, Feb. 09, 2018 -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of AECOM (NYSE:ACM),...
Feb 09, 2018 13:00 pm UTC| Business
BRIDGEWATER, N.J., Feb. 09, 2018 -- Valeritas Holdings, Inc. (NASDAQ:VLRX), a medical technology company which offers patients with type 2 diabetes V-Go® Wearable Insulin Delivery device, a simple, affordable,...
MOXY Hotels’ first-ever Washington, D.C. location features a new restaurant with a retractable-roof
Feb 09, 2018 13:00 pm UTC| Business
OAKVILLE, Ontario, Feb. 09, 2018 -- America’s capital city is about to get a fresh new destination that will give visitors an inviting place to stay, enjoy a great meal and see the many local sights. The MOXY Hotel in...
CarGurus to Present at Goldman Sachs Technology & Internet Conference
Feb 09, 2018 13:00 pm UTC| Business
CAMBRIDGE, Mass., Feb. 09, 2018 -- CarGurus, Inc. (NASDAQ:CARG), a leading global automotive marketplace, today announced that Jason Trevisan, Chief Financial Officer, and Scot Fredo, Vice President of FPA, are...
Technical Communications Corporation Reports Results for the Fiscal Quarter Ended December 30, 2017
Feb 09, 2018 13:00 pm UTC| Business
CONCORD, Mass., Feb. 09, 2018 -- Technical Communications Corporation (NasdaqCM:TCCO) today announced its results for the fiscal quarter ended December 30, 2017. For the quarter ended December 30, 2017, the Company...
Enhanced MuScreen™ Platform Revolutionizes Preclinical Development of Immunotherapeutics
Feb 09, 2018 13:00 pm UTC| Business
SAN DIEGO, Feb. 09, 2018 -- Crown Bioscience, a wholly-owned subsidiary of Crown Bioscience International (TWSE:6554) and a global drug discovery and development services company providing translational platforms to...